Latest Data & Reports

China’s NHSA has launched the first national basic medical insurance catalog for medical service items, covering 13 clinical categories. Together with standardized pricing items and consumables reimbursement reform, the policy is creating a more unified payment framework for medical device market access.

In the first half of 2026, China’s surgical robot market continued to develop across multiple system categories in parallel.

As of June 30, 2026, MedRobot’s analysis of publicly disclosed procurement awards from public hospitals in mainland China

As of June 30, 2026, MedRobot's analysis of publicly disclosed procurement awards from public hospitals across mainland China.

With at least 611 systems sold in 2025, China’s surgical robot market is shifting from concept-driven growth to structured, clinically led expansion across multiple surgical specialties.

In 2025, 52 NMPA approvals were granted to surgical robots developed by Chinese companies, including both new systems and indication expansions. Orthopedics accounted for the largest share, with 23 approvals.